The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and antidopaminergic activity of some 3-(aminomethyl)tetralones as analogues of butyrophenone.EBI
University of Santiago De Compostela
Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold.EBI
University of Santiago De Compostela
2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.EBI
University of Santiago De Compostela
Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.EBI
University of Santiago De Compostela
Aromatic ring functionalization of benzolactam derivatives: new potent dopamine D3 receptor ligands.EBI
University of Santiago De Compostela
Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.EBI
University of Santiago De Compostela
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.EBI
University of Santiago De Compostela
Further Studies on the Highly Active Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin DEBI
University of Santiago De Compostela
Exploring the Effect of Halogenation in a Series of Potent and Selective AEBI
University of Santiago de Compostela
A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.EBI
University of Santiago De Compostela
Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin DEBI
University of Santiago De Compostela
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists.EBI
University of Santiago De Compostela
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.EBI
University of Santiago De Compostela
Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2'-furyl)-1,2,4-triazolo[1,5-a]quinoxalines.EBI
University of Santiago De Compostela
Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.EBI
University of Santiago De Compostela
Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists.EBI
University of Santiago De Compostela